Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview

Molecular Neurobiology
João Paulo CapelaFélix Carvalho


"Ecstasy" [(+/-)-3,4-methylenedioxymethamphetamine, MDMA, XTC, X, E] is a psychoactive recreational hallucinogenic substance and a major worldwide drug of abuse. Several reports raised the concern that MDMA has the ability to induce neurotoxic effects both in laboratory animals and humans. Despite more than two decades of research, the mechanisms by which MDMA is neurotoxic are still to be fully elucidated. MDMA induces serotonergic terminal loss in rats and also in some mice strains, but also a broader neuronal degeneration throughout several brain areas such as the cortex, hippocampus, and striatum. Meanwhile, in human "ecstasy" abusers, there are evidences for deficits in seronergic biochemical markers, which correlate with long-term impairments in memory and learning. There are several factors that contribute to MDMA-induced neurotoxicity, namely, hyperthermia, monoamine oxidase metabolism of dopamine and serotonin, dopamine oxidation, the serotonin transporter action, nitric oxide, and the formation of peroxinitrite, glutamate excitotoxicity, serotonin 2A receptor agonism, and, importantly, the formation of MDMA neurotoxic metabolites. The present review covered the following topics: history and epidemiology, pharmacologic...Continue Reading


Jan 1, 1976·Annual Review of Pharmacology and Toxicology·H G Baumgarten, A Björklund
Jul 4, 1992·BMJ : British Medical Journal·J A Henry
Oct 1, 1992·Free Radical Biology & Medicine·A BindoliD J Deeble
Feb 1, 1991·Pharmacology, Biochemistry, and Behavior·C J GordonD B Miller
Nov 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·F J CreightonC E Hyde
May 31, 1990·European Journal of Pharmacology·C J Schmidt, V L Taylor
May 31, 1990·European Journal of Pharmacology·C J SchmidtV L Taylor
Jan 1, 1990·Annals of the New York Academy of Sciences·M E MolliverM A Wilson
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
May 13, 1986·European Journal of Pharmacology·C J SchmidtW Lovenberg
Feb 1, 1988·Pharmacology, Biochemistry, and Behavior·G BattagliaE B De Souza
Jul 1, 1988·JAMA : the Journal of the American Medical Association·George A RicaurteJ W Langston
Jul 1, 1986·American Journal of Psychotherapy·L Grinspoon, J B Bakalar
Mar 29, 1988·European Journal of Pharmacology·B K Yamamoto, L J Spanos
Apr 27, 1988·European Journal of Pharmacology·G BattagliaE B De Souza
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J SeidegårdW R Pearson
Oct 16, 1971·The Veterinary Record
Mar 1, 1982·Journal of Neurochemistry·C J Fowler, K F Tipton
Apr 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Una D McCannGeorge A Ricaurte
Apr 1, 1995·Psychopharmacology·J E Sprague, D E Nichols
Aug 16, 1995·Biochimica Et Biophysica Acta·K LundströmI Ulmanen
Oct 1, 1994·The Journal of Pharmacy and Pharmacology·J L Fitzgerald, J J Reid


Mar 7, 2012·Archives of Toxicology·Márcia CarvalhoMaria Lourdes Bastos
Jan 7, 2010·Journal of Neural Transmission·Norbert GyongyosiGyorgy Bagdy
Feb 17, 2010·Neuropsychology Review·Claire E NulsenGeoffrey R Hammond
Aug 26, 2010·Journal of the International Neuropsychological Society : JINS·Chad A BousmanHNRC Group
May 12, 2011·Chemical Research in Toxicology·Anne NeudörfferMartine Largeron
Feb 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amy L BauernfeindRonald L Cowan
Jan 21, 2012·Addiction Biology·Xavier ViñalsPatricia Robledo
Jul 25, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Melanie MuellerGeorge A Ricaurte
Nov 2, 2013·Archives of Toxicology·Daniel José BarbosaFélix Carvalho
Nov 16, 2013·Analytical and Bioanalytical Chemistry·Rebecca L HartmanMarilyn A Huestis
Dec 10, 2013·Bioinformatics·Hongjie Zhu, Man Luo
Dec 3, 2013·Acta Neuropathologica·Jean Lud CadetChristopher Mark Milroy
Nov 22, 2013·Neurotoxicity Research·N GranadoR Moratalla
Feb 4, 2014·Neuropharmacology·Maude Beaudoin-Gobert, Véronique Sgambato-Faure
Apr 1, 2014·Journal of Analytical Toxicology·Corinne RamaleyChengan Du
Mar 5, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Joseph M HerndonTerrence J Monks
Jun 21, 2014·Pharmacological Reports : PR·Anna Maria GórskaKrystyna Gołembiowska
Mar 7, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Daniel José BarbosaFélix Carvalho
Feb 14, 2014·Archives of Toxicology·Daniel José BarbosaEduardo Soriano
Apr 19, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Leo J SchepPaul Gee
Jan 10, 2016·Neuroscience and Biobehavioral Reviews·F MuellerS Borgwardt
Nov 28, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marzieh GhaderiMohammad-Reza Zarrindast
Nov 28, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jui-Hu ShihI-Hsun Li
Feb 6, 2013·Behavioural Brain Research·Nadine Y LettfussAndreas von Ameln-Mayerhofer
Dec 26, 2012·Neurotoxicology·Laura HondebrinkRemco H S Westerink
Dec 1, 2012·Toxicology Letters·Patrícia Silva FerreiraJoão Paulo Capela

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.